Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphoma
ConclusionLIP at baseline may predict refractory disease and exhibits a prognostic value in CNS-DLBCL patients.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Cancer & Oncology | Chemotherapy | Lymphoma | Neurology | Primary CNS Lymphoma | Rituxan